Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Current Assets (2020 - 2025)

RxSight's Current Assets history spans 6 years, with the latest figure at $287.5 million for Q4 2025.

  • For Q4 2025, Current Assets fell 2.17% year-over-year to $287.5 million; the TTM value through Dec 2025 reached $287.5 million, down 2.17%, while the annual FY2025 figure was $287.5 million, 2.17% down from the prior year.
  • Current Assets reached $287.5 million in Q4 2025 per RXST's latest filing, up from $283.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $293.8 million in Q4 2024 to a low of $75.5 million in Q2 2021.
  • Average Current Assets over 5 years is $205.3 million, with a median of $180.4 million recorded in 2023.
  • Peak YoY movement for Current Assets: surged 116.31% in 2021, then fell 25.32% in 2022.
  • A 5-year view of Current Assets shows it stood at $176.3 million in 2021, then dropped by 23.68% to $134.6 million in 2022, then increased by 25.16% to $168.4 million in 2023, then soared by 74.47% to $293.8 million in 2024, then dropped by 2.17% to $287.5 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Current Assets are $287.5 million (Q4 2025), $283.9 million (Q3 2025), and $283.9 million (Q2 2025).